Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 3-bromo-4-chlorobenzoic acid | 42860-10-6 | MFCD00079706 | 100.0% | 235.46 g·mol⁻¹ | C7H4BrClO2 | 50 G
SDP

Catalog No. 5000301070
Encompass_Preferred

3-Bromo-4-chlorobenzoic acid is a brominated and chlorinated benzoic acid used as an intermediate in organic and pharmaceutical synthesis. It is reported as Dapagliflozin Impurity 50 and is supplied for research, method development, and impurity profiling, with high listed purity and multiple packaging options.

  • High purity suitable for synthetic applications.
  • Useful intermediate for medicinal chemistry and impurity studies.
  • Defined molecular formula and molecular weight for analytical work.
  • Available in a range of packaging sizes for scale flexibility.
  • Suitable as an analytical reference standard in method development.

Catalog No. 50-003-01070 Supplier Medchemexpress LLC Supplier No. HYW01869750G
May include imposed supplier surcharges.
Add to Cart
Add to Cart

3-Bromo-4-chlorobenzoic acid is a brominated and chlorinated benzoic acid used as an intermediate in organic and pharmaceutical synthesis. It is reported as Dapagliflozin Impurity 50 and is supplied for research, method development, and impurity profiling, with high listed purity and multiple packaging options.

  • High purity suitable for synthetic applications.
  • Useful intermediate for medicinal chemistry and impurity studies.
  • Defined molecular formula and molecular weight for analytical work.
  • Available in a range of packaging sizes for scale flexibility.
  • Suitable as an analytical reference standard in method development.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.